BioCentury
ARTICLE | Emerging Company Profile

Heranova: Detecting endometriosis in the blood like it’s cancer

The Massachusetts-based company launched a microRNA-based liquid biopsy test for endometriosis, with an eye toward disease monitoring and drug development

March 27, 2025 11:13 PM UTC

Heranova thinks the similarities between endometriosis and cancer will make the notoriously difficult-to-diagnose disease amenable to non-invasive detection via liquid biopsy of nucleic acids from uterine lining cells undergoing excessive growth, which opens to door to use cases beyond yes/no diagnoses.

“Endometriosis behaves like a cancer,” Farideh Bischoff, CMO and head of diagnostics at Burlington, Mass-based Heranova Lifesciences Inc., told BioCentury. “The mechanisms by which this disease progresses and develops results in the shedding of material in the blood.” ...

BCIQ Company Profiles

Heranova Lifesciences Inc.